Concord Biotech (CONCORDBIO.NSE) Q3 2024 Earnings

Aug 10Confirmed
Q4 2023
Q2 2024
Q3 2024
5.74
6.85
7.97
9.09

Details

Expected EPS
6.54101435715
Actual EPS
5.73596643627
Surprise EPS
-0.81
Surprise Percent
-12.31%

Description

⁨Concord Biotech⁩ (⁦CONCORDBIO.NSE⁩) has reported earnings of ⁦5.73596643627⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts